C92.1 Chronic myeloid leukemia, BCR/ABL-positive

⚠ Non-Billable ICD-10-CM 2026
Open C92.1 in Web App →

The ICD-10-CM code for Chronic myeloid leukemia, BCR/ABL-positive is C92.1 (FY2026). It is a non-billable category code — select a more specific code below for claims.

Classification

Section
C81-C96: Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96)
Category C92
41 codes (30 billable)
FY2026 Status
Stable since FY2024

Also Known As

ICD-10-CM Alphabetic Index entries that lead to C92.1:

  • Leukemia, leukemic › chronic myeloid, BCR/ABL-positive
  • Leukemia, leukemic › chronic myelogenous (Philadelphia chromosome (Ph1) positive) (t(9;22)) (q34;q11) (with crisis of blast cells)
Excludes1
Not coded here. These conditions should NOT be coded together with C92.1.
  • atypical chronic myeloid leukemia BCR/ABL-negative (C92.2-)
  • chronic myelomonocytic leukemia (C93.1-)
  • chronic myeloproliferative disease (D47.1)

Inclusion Terms

  • Chronic myelogenous leukemia, Philadelphia chromosome (Ph1) positive
  • Chronic myelogenous leukemia, t(9;22) (q34;q11)
  • Chronic myelogenous leukemia with crisis of blast cells

Official Coding Guidelines

Tx of primary site (TOC entry)

a. Admission/Encounter for treatment of primary site ............................................................. 33

— ICD-10-CM Official Guidelines for Coding and Reporting, FY2026, Section I.C.2.a
Tx of secondary site (TOC entry)

b. Admission/Encounter for treatment of secondary site .......................................................... 33

— ICD-10-CM Official Guidelines for Coding and Reporting, FY2026, Section I.C.2.b

Source: CMS — ICD-10-CM Official Guidelines for Coding and Reporting, FY2026

References

Related Codes

Search all 70,000+ ICD-10-CM codes →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2025-10-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial